Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USV
Mumbai, Maharashtra, Indiausvindia.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
USV is a leading Indian pharmaceutical and biotechnology company with global operations. It manufactures and supplies custom peptides at both research and commercial scale under GMP conditions. The company has three synthetic peptide APIs approved in multiple countries—icatibant, etelcalcetide, and octreotide acetate—and offers custom synthesis services for complex peptides. Its facilities are approved by major regulatory agencies including the US FDA.
- Therapeutic areas
- EndocrinologyImmunologyNephrology
- Modalities
- Small moleculePeptidesBiosimilars
- Industry
- Biotech
02
Partnerships
Markets Sebamed products in IndiaMarkets Fujix Corp's products outside Japan/US
Beyond the preview
Go deeper on USV.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on USV.